Il10 agonists and methods of use thereof
US-2025333464-A1 · Oct 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Ioffe Ella patents
Ioffe Ella is listed as an inventor on 41 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Ioffe Ella |
| Total patents | 41 |
| First publication | Jul 23, 2015 |
| Latest publication | Oct 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Mouse having a humanized cluster of differentiation 47 gene
US-12389889-B2 · Aug 19, 2025 · US
Anti-CTLA-4 Antibodies and Uses Thereof
US-2025122307-A1 · Apr 17, 2025 · US
Human antibodies to pd-l1
US-2025092139-A1 · Mar 20, 2025 · US
IL10 agonists and methods of use thereof
US-12187772-B2 · Jan 7, 2025 · US
Human Antibodies To PD-1
US-2024316361-A1 · Sep 26, 2024 · US
Anti-CTLA-4 antibodies and uses thereof
US-12024570-B2 · Jul 2, 2024 · US
Anti-lag3 antibodies and uses thereof
US-2024166740-A1 · May 23, 2024 · US
Non-human animals having a humanized cluster of differentiation 47 gene
US-2024138384-A1 · May 2, 2024 · US
Mouse having a humanized cluster of differentiation 47 gene
US-11910788-B2 · Feb 27, 2024 · US
Recent patents
Latest publications not already listed above.
Novel il10 agonists and methods of use thereof
US-2023279070-A1 · Sep 7, 2023 · US
Methods for Treating Cancer with Bispecific Anti-CD3 x MUC16 Antibodies and Anti-CTLA-4 Antibodies
US-2023235089-A1 · Jul 27, 2023 · US
Anti-LAG3 antibodies and uses thereof
US-11692032-B2 · Jul 4, 2023 · US
IL10 agonists and methods of use thereof
US-11673930-B2 · Jun 13, 2023 · US
Human antibodies to pd-l1
US-2021380702-A1 · Dec 9, 2021 · US
Novel il10 agonists and methods of use thereof
US-2021355184-A1 · Nov 18, 2021 · US
Human antibodies to PD-L1
US-11117970-B2 · Sep 14, 2021 · US
Non-human animals having a humanized cluster of differentiation 47 gene
US-2021161112-A1 · Jun 3, 2021 · US
Method of using mouse having a humanized cluster of differentiation 47 gene
US-10939673-B2 · Mar 9, 2021 · US
Anti-CTLA-4 Antibodies and Uses Thereof
US-2021040232-A1 · Feb 11, 2021 · US
Anti-CTLA-4 antibodies and uses thereof
US-10844137-B2 · Nov 24, 2020 · US
Human antibodies to pd-1
US-2020330794-A1 · Oct 22, 2020 · US
Human antibodies to PD-1
US-10737113-B2 · Aug 11, 2020 · US
Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody
US-10532096-B2 · Jan 14, 2020 · US
Anti-lag3 antibodies and uses thereof
US-2019284277-A1 · Sep 19, 2019 · US
Anti-LAG3 antibodies and uses thereof
US-10358495-B2 · Jul 23, 2019 · US
Anti-CTLA-4 Antibodies and Uses Thereof
US-2019048096-A1 · Feb 14, 2019 · US
Non-human animals having a humanized cluster of differentiation 47 gene
US-2018249689-A1 · Sep 6, 2018 · US
Methods and compositions comprising a combination of a vegf antagonist and an anti-ctla-4 antibody
US-2018236070-A1 · Aug 23, 2018 · US
Non-human animals having a humanized cluster of differentiation 47 gene
US-10015953-B2 · Jul 10, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Regeneron Pharma | 41 |
| Regeneran Pharmaceuticals Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 41 |
| C07K2317/76 | 27 |
| C07K2317/21 | 22 |
| C07K2317/92 | 22 |
| A61K2039/507 | 21 |